CIPLA, a global pharmaceutical giant, is expanding its operations into Ghana, aiming to invest in the country’s development beyond simply providing medicines, the Chief Executive Officer of CIPLA Africa, Paul Miller, has said.
As CIPLA launched its presence in the country, Mr. Miller outlined its plans to empower local communities through job creation, infrastructure development, and sustainable economic growth initiatives.
During a recent media event, in Accra, he highlighted CIPLA’s commitment to exploring local manufacturing opportunities, emphasizing the positive impact such ventures can have on the economy. While initially setting up a distribution office in Ghana, the company remains open to establishing manufacturing facilities in the future.
In terms of product offerings, CIPLA is introducing a range of therapeutic solutions in Ghana, covering respiratory, gastrointestinal, cardiovascular, diabetes management, pain relief, cold, flu, and anti-infective medications.
“Affordability is a key focus for CIPLA,” Miller said, stressing the company’s dedication to ensuring access to quality medicines across all income levels.
He expressed a vision of fostering a healthy population in partnership with the government, healthcare practitioners, and patients.
Ahead of the media launch, the company in a statement said its decision to move into the country forms part of its “Africa for Africa” strategy and is also in line with ensuring equitable access to quality medication across the continent.
Mr. Miller, said: “We envision a future where everyone in Ghana has equitable access to quality, life-saving medicine, and innovative therapies.
“In line with the United Nations Sustainable Development Goals, we are focused on improving health and promoting well-being.
Addressing disparities by enabling access to medication is one of the most important things we can do in any country to help improve health outcomes. Because we believe that healthy people are the foundation of healthy economies. We want to unlock our continent’s wellbeing potential and drive inclusive economic growth.”
Beyond medication provision, CIPLA during the launch also indicated that it has been collaborating with local partners to facilitate corrective surgery for individuals with cleft conditions. Additionally, the company aims to address the mental well-being of healthcare professionals.
Through initiatives like ‘CrazySocksDocs,’ it was highlighted at the media event that CIPLA seeks to create a supportive environment for healthcare workers, acknowledging the challenges they face, particularly highlighted during events like the COVID-19 pandemic.
Mr. Miller emphasized the importance of supporting healthcare professionals’ mental health, noting the pressures they endure in their roles and the stigma often associated with seeking CEO of Cipla Africa, help.
“By fostering an open dialogue and providing resources for mental health support, CIPLA aims to ensure better health outcomes for both patients and practitioners alike,” CIPLA Africa CEO added.
